HY-07121

N/A

Report date: 2025/03/03 14:53:52

Base Information

Drug NameHY-07121
Drug Alias NameHY07121HY-07121
ClassificationBiologics > Protein drugs > Immunoglobulin > AntibodyBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionAnti-PD-1Anti-T cell immunoglobulin and ITIM domainsAnti-IL15
TargetsProgrammed cell death protein 1T cell immunoglobulin and ITIM domainsInterleukin-15
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesSichuan Huiyu Seacross Pharma Technology Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesSichuan Huiyu Seacross Pharma Technology LtdThousand Oaks Biopharmaceuticals Co LtdSichuan Huiyu Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A